Circadian disruption, clock genes, and metabolic health
Journal of Clinical Investigation · 15.07.2024 · 134 (14)
DOI: 10.1172/jci170998 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2024. Verfasst von Lauren A Schrader und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Environmental Toxicology Center and. Hauptthemen laut MEDLINE: Circadian Rhythm, CLOCK Proteins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 221-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
A growing body of research has identified circadian-rhythm disruption as a risk factor for metabolic health. However, the underlying biological basis remains complex, and complete molecular mechanisms are unknown. There is emerging evidence from animal and human research to suggest that the expression of core circadian genes, such as circadian locomotor output cycles kaput gene ( CLOCK ), brain and muscle ARNT-Like 1 gene ( BMAL1 ), period ( PER ), and cryptochrome ( CRY ), and the consequent expression of hundreds of circadian output genes are integral to the regulation of cellular metabolism. These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes. Here, we aim to summarize select evidence from in vivo animal models and compare these results with epidemiologic research findings to advance understanding of existing foundational evidence and potential mechanistic links between circadian disruption and altered clock gene expression contributions to metabolic health–related pathologies. Findings have important implications for the treatment, prevention, and control of metabolic pathologies underlying leading causes of death and disability, including diabetes, cardiovascular disease, and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular and Environmental Toxicology Center and.
- Department of Surgery, Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin, Madison Wisconsin, USA.
- Divisions of Human Genetics and Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Oncology and.
- Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
- Division of Environmental and Occupational Health Sciences, University of Illinois Chicago, Chicago, Illinois, USA.
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIA NIH HHS
Zitieren
APA
Schrader, L. A., Ronnekleiv-Kelly, S. M., Hogenesch, J. B., Bradfield, C. A., & Malecki, K. M. (2024). Circadian disruption, clock genes, and metabolic health. Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/jci170998
Vancouver
Schrader LA, Ronnekleiv-Kelly SM, Hogenesch JB, Bradfield CA, Malecki KM. Circadian disruption, clock genes, and metabolic health. Journal of Clinical Investigation. 2024;134(14). doi:10.1172/jci170998
BibTeX
@article{Schrader2024,
author = {Schrader, Lauren A and Ronnekleiv-Kelly, Sean M and Hogenesch, John B and Bradfield, Christopher A and Malecki, Kristen Mc},
title = {Circadian disruption, clock genes, and metabolic health},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {14},
doi = {10.1172/jci170998}
}
EUVIMED